Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

BIT/1MRNA stock hub

BIT/1MRNA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BIT/1MRNAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

18.3B

Borsa Italiana

Market data

Live price

Current market quote for this ticker.

Current price

BIT/1MRNA

In the news

Latest news · BIT/1MRNA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-36.6

P25 n/aP50 n/aP75 n/a

ROIC-66.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BIT/1MRNA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

164

Groups with data

Currency

USD

Showing 164 of 164 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	IT
Employees	4,700
Employees Change	-1,100%
Employees Change Percent	-18.97
Enterprise value	EUR 13.1B
Exchange	Borsa Italiana
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 18.3B
Price	EUR 46.4
Price currency	EUR
Rev Per Employee	410,583.51x
Sic	2836
Symbol	bit/1MRNA
Website	https://www.modernatx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-15.12%
EV Earnings	-4.73x
EV/FCF	-9.42x
EV/Sales	6.92x
FCF yield	-7.59%
P/B ratio	2.85x
P/S ratio	9.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-113.89%
EBITDA Margin	-103.33%
Gross margin	-69.89%
Gross Profit	EUR -1.3B
Net Income	EUR -2.8B
Pretax Margin	-141.03%
Profit Margin	-143.55%
Profit Per Employee	EUR -589,395
ROA	-13.09
Roa5y	6.72
ROCE	-27.87
ROE	-36.56
Roe5y	22.02
ROIC	-66.19
Roic5y	177.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	98.76%
Cagr3y	-30.09%
Revenue Growth	-29.97x
Revenue Growth Q	260.19x
Revenue Growth3 Y	-47.13x
Revenue Growth5 Y	-4.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.18
Assets	EUR 10B
Cash	EUR 4.5B
Current Assets	EUR 4.9B
Current Liabilities	EUR 2B
Debt	EUR 1.1B
Debt Equity	EUR 0.18
Debt FCF	EUR -0.81
Equity	EUR 6.4B
Interest Coverage	-97.46
Liabilities	EUR 3.5B
Long Term Assets	EUR 5.1B
Long Term Liabilities	EUR 1.5B
Net Cash	EUR 5.3B
Net Cash By Market Cap	EUR 29.15
Net Cash Growth	-19.48%
Net Debt Equity	EUR -0.83
Tangible Book Value	EUR 6.3B
Tangible Book Value Per Share	EUR 15.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.41
Inventory Turnover	27.59
Net Working Capital	EUR -1.5B
Quick ratio	2.23
Working Capital	EUR 2.9B
Working Capital Turnover	EUR 0.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.62%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	98.67%
200-day SMA	30.84
3Y total return	-65.84%
50-day SMA	44.34
50-day SMA vs 200-day SMA	50over200
All Time High	201.1
All Time High Change	-79.19%
All Time High Date	2022-12-14
All Time Low	19.38
All Time Low Change	115.89%
All Time Low Date	2025-11-21
ATR	2.58
Ch YTD	59.45
High	48.01
High52	50.5
High52 Date	2026-03-05
High52ch	-8.13%
Low	41.57
Low52	19.38
Low52 Date	2025-11-21
Low52ch	139.4%
Ma50ch	-5.63%
Price vs 200-day SMA	35.66%
RSI	59.39
RSI Monthly	47.54
RSI Weekly	66.07
Sharpe ratio	1.38x
Sortino ratio	2.36
Total Return	-1.62%
Tr YTD	59.45
Tr1m	0.32%
Tr1w	2.89%
Tr3m	22.45%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -2.2B
Operating margin	-113.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	370,094,602%
Net Borrowing	491,817,960
Shares Insiders	6.64%
Shares Institutions	80.34%
Shares Qo Q	0.77%
Shares Yo Y	1.62%
Short Ratio	7.4

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -1.8B
Average Volume	9,043.7x
Bv Per Share	16.18
CAPEX	EUR -118.8M
Ch1m	0.32
Ch1w	2.89
Ch1y	98.67
Ch3m	22.45
Ch3y	-65.84
Ch6m	105.6
Change	12.27%
Change From Open	10.7
Close	41.33
Days Gap	1.42
Depreciation Amortization	199,271,070
Dollar Volume	1,492,341.6
Earnings Date	2026-05-01
EBIT	EUR -2.2B
EBITDA	EUR -2B
EPS	EUR -7.08
F Score	2
FCF	EUR -1.4B
FCF EV Yield	-10.62x
Financing CF	525,583,800
Fiscal Year End	December
Founded	2,010
Goodwill	44,094,024
Income Tax	EUR 48.6M
Investing CF	988,722,000
Is Primary Listing	0
Last Earnings Date	2026-05-01
Last Report Date	2026-03-31
Ma150	33.49
Ma150ch	24.95%
Ma20	43.53
Ma20ch	-3.88%
Net CF	245,445,900
Open	41.91
Position In Range	74.92
Ppne	2,367,509,904
Price Date	2026-05-08
Ptbv Ratio	2.92
Relative Volume	3.56x
Revenue	1,929,742,500x
SBC By Revenue	21.21x
Share Based Comp	409,365,600
Tax By Revenue	2.52x
Tr6m	105.55%
Volume	32,166
Z Score	2.36

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BIT/1MRNA pay a dividend?

Capital-return profile for this ticker.

Performance

BIT/1MRNA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BIT/1MRNA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+80.3%

Share of float held by funds and institutions

Insider ownership

+6.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BIT/1MRNA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.4

Neutral momentum band

Price vs 200-day MA

+35.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.38

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BIT/1MRNA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bit/1MRNA stock rating?

bit/1MRNA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bit/1MRNA analysis?

The full report lives at /stocks/bit/1MRNA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bit/1MRNA?

The latest report frames bit/1MRNA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bit/1MRNA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.